Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 16 of 27
 |<   <<   <  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  >   >>   >| 

Scientific Advancements
Thursday, March 11, 2021   (0 Comments - view/add)
Longeveron’s Lomecel-B™ Approved by FDA for Compassionate Use for the Treatment of Child with Hypopl »
Longeveron’s Lomecel-B™ Approved by FDA for Compassionate Use for the Treatment of Child with Hypoplastic Left Heart S...
Thursday, March 11, 2021   (0 Comments - view/add)
OrganaBio Launches Its HematoPAC™ Cord Blood-Derived CD34+ Hematopoietic Stem Cells (HSCs) »
OrganaBio Launches Its HematoPAC™ Cord Blood-Derived CD34+ Hematopoietic Stem Cells (HSCs)...
Saturday, March 6, 2021   (0 Comments - view/add)
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investiga »
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Ther...
Thursday, March 4, 2021   (0 Comments - view/add)
Cyclo Therapeutics Announces Last Patient Last Visit in Phase 1/2 Trial Evaluating Trappsol® Cyclo™ »
Cyclo Therapeutics Announces Last Patient Last Visit in Phase 1/2 Trial Evaluating Trappsol ® Cyclo™ for the Treatment of...
Wednesday, March 3, 2021   (0 Comments - view/add)
Marker Therapeutics Announces Dosing of First Patient in Phase 2 Trial of MT-401 in Acute Myeloid Le »
Marker Therapeutics Announces Dosing of First Patient in Phase 2 Trial of MT-401 in Acute Myeloid Leukemia Following S...
Wednesday, March 3, 2021   (0 Comments - view/add)
ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence He »
ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Colle...
Tuesday, March 2, 2021   (0 Comments - view/add)
KemPharm Announces FDA Approval of AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsules »
KemPharm Announces FDA Approval of AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsules, for oral use, CII...
Saturday, February 27, 2021   (0 Comments - view/add)
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine »
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine Action Advances Fight Against COVID...
Saturday, February 27, 2021   (0 Comments - view/add)
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use - First Single-Shot Vacc »
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use - First Single-Shot Vaccine in Fight A...
Wednesday, February 24, 2021   (0 Comments - view/add)
AIM ImmunoTech’s Subsidiary Receives Orphan Medicinal Product Designation by the European Medicines »
AIM ImmunoTech’s Subsidiary Receives Orphan Medicinal Product Designation by the European Medicines Agency for Amplige...
Wednesday, February 24, 2021   (0 Comments - view/add)
Longeveron Announces Successful Completion of Phase 1 Clinical Study of Lomecel-B Intramyocardial In »
Longeveron Announces Successful Completion of Phase 1 Clinical Study of Lomecel-B Intramyocardial Injection in Hypopla...
Wednesday, February 24, 2021   (0 Comments - view/add)
FDA says single-dose shot from J&J prevents severe COVID »
FDA says single-dose shot from J&J prevents severe COVID  ...
Monday, February 22, 2021   (0 Comments - view/add)
Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal System for ADHD »
Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal System for ADHD...
Thursday, February 18, 2021   (0 Comments - view/add)
Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis »
Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis Pilot study demonstrates clinically significant imp...
Tuesday, February 9, 2021   (0 Comments - view/add)
Cyclo Therapeutics Presents Positive Data from Clinical Development Program for Lead Candidate, Trap »
Cyclo Therapeutics Presents Positive Data from Clinical Development Program for Lead Candidate, Trappsol ® Cyclo™, at WOR...
Tuesday, February 9, 2021   (0 Comments - view/add)
Lilly's bamlanivimab (LY-CoV555) administered with etesevimab (LY-CoV016) receives FDA emergency use »
Lilly's bamlanivimab (LY-CoV555) administered with etesevimab (LY-CoV016) receives FDA emergency use authorization fo...
Thursday, February 4, 2021   (0 Comments - view/add)
Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorizatio »
Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its...
Friday, January 29, 2021   (0 Comments - view/add)
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in »
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim...
Thursday, January 28, 2021   (0 Comments - view/add)
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial »
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial...
Wednesday, January 27, 2021   (0 Comments - view/add)
AGTC Announces First Reported Improvements in Visual Sensitivity for Achromatopsia (ACHM) patients f »
AGTC Announces First Reported Improvements in Visual Sensitivity for Achromatopsia (ACHM) patients from its Ongoing Cl...
Wednesday, January 27, 2021   (0 Comments - view/add)
KemPharm Receives FDA Clearance to Initiate KP879 Clinical Program for the Treatment of Stimulant Us »
KemPharm Receives FDA Clearance to Initiate KP879 Clinical Program for the Treatment of Stimulant Use Disorder...
Thursday, January 14, 2021   (0 Comments - view/add)
Monday, January 11, 2021   (0 Comments - view/add)
Morphogenesis to Initiate Phase 1 Trial of IFx-Hu2.0 for Treatment of Early-Stage Skin Cancers »
FOR IMMEDIATE RELEASE Morphogenesis to Initiate Phase 1 Trial of IFx-Hu2.0 for Treatment of Early...
Monday, January 11, 2021   (0 Comments - view/add)
Jupiter Orphan Therapeutics Announces First Patient Dosed in Phase I Dose Escalation Study of JOTROL »
Jupiter Orphan Therapeutics Announces First Patient Dosed in Phase I Dose Escalation Study of JOTROL™...
Wednesday, January 6, 2021   (0 Comments - view/add)
AIM ImmunoTech Announces First COVID-19-Induced Chronic Fatigue “Long Hauler” Patient Dosed with Amp »
AIM ImmunoTech Announces First COVID-19-Induced Chronic Fatigue “Long Hauler” Patient Dosed with Ampligen AIM to...
Thursday, December 24, 2020   (0 Comments - view/add)
AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollme »
AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 ‘Lo...
Tuesday, December 22, 2020   (0 Comments - view/add)
KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder »
KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder Celebration, FL – December...
Monday, December 21, 2020   (0 Comments - view/add)
AIM ImmunoTech Inc.’s Drug Ampligen Awarded FDA’s Orphan Drug Designation Status for the Treatment o »
AIM ImmunoTech Inc.’s Drug Ampligen Awarded FDA’s Orphan Drug Designation Status for the Treatment of Pancreatic Cancer...
Saturday, December 19, 2020   (0 Comments - view/add)
U.S. CDC Advisory Committee on Immunization Practices Recommends Vaccination with Moderna’s COVID-19 »
U.S. CDC Advisory Committee on Immunization Practices Recommends Vaccination with Moderna’s COVID-19 Vaccine for Persons...
Friday, December 18, 2020   (0 Comments - view/add)
Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S. »
Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S. December 18, 2020 at 7:46 PM EST...
Thursday, December 17, 2020   (0 Comments - view/add)
Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Monoclonal Antibodies »
Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Monoclonal Antibodies...
Thursday, December 17, 2020   (0 Comments - view/add)
Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against »
Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against COVID-19 in the Un...
Tuesday, December 15, 2020   (0 Comments - view/add)
‘Functionalized fragments’ help design RNA medicines for undruggable diseases »
Scripps Research | For immediate release ‘Functionalized fragments’ help design RNA medicines for undruggab...
Tuesday, December 15, 2020   (0 Comments - view/add)
FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test »
FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test...
Monday, December 14, 2020   (0 Comments - view/add)
Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response »
Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunizati...

Displaying page 16 of 27
 |<   <<   <  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  >   >>   >| 

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians. Source: TEConomy/BIO (released 2022)